» Articles » PMID: 12884422

Case-control Study of Cleft Lip or Palate After Maternal Use of Topical Corticosteroids During Pregnancy

Overview
Specialty Genetics
Date 2003 Jul 29
PMID 12884422
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

A case-control survey of 48 children with nonsyndromic cleft lip or palate showed a significant increase in prevalence of maternal use of topical corticosteroid preparations in the first trimester of pregnancy, compared to 58 controls born in the same hospital; the odds ratio was 13.154, 95% confidence interval 1.67-586, P = 0.0049 on Fisher's exact two-tail test. The results were statistically significant although the wide confidence interval reflected the small sample size. Although older epidemiological studies have not detected any association between systemic corticosteroid treatment and the combined incidence of all congenital malformations, experimental studies over several decades have shown that maternal corticosteroid exposure in several species of animals is specifically associated with oral clefts. This association has been confirmed by more specific case-control surveys where the cases were children with cleft lip or palate and the exposure was maternal systemic corticosteroid treatment in the first trimester. Only one previous survey also analyzed topical corticosteroids, and it demonstrated an increased odds ratio for cleft lip or palate. A national survey of children with cleft palate will be necessary to evaluate the results of this pilot study.

Citing Articles

Increased prevalence of negative pregnancy and fetal outcomes in women with primary adrenal insufficiency. A systematic review and meta-analysis.

Ilia G, Paltoglou G, Chatzakis C, Christopoulos P, Tzitiridou-Chatzopoulou M, Mastorakos G Endocrine. 2024; 86(3):1156-1170.

PMID: 39277840 DOI: 10.1007/s12020-024-04023-8.


Effect of elevated temperature and hydrocortisone addition on the proliferation of fibroblasts.

Pavlikova Z, Zahradnicek O, Jelinek Michaelidesova A, Sramek J, Davidkova M, Hovorakova M Histochem Cell Biol. 2024; 162(3):231-244.

PMID: 38801536 PMC: 11322275. DOI: 10.1007/s00418-024-02295-9.


Pregnancy in Patients with Inflammatory Bowel Diseases-A Literature Review.

Grigorescu R, Husar-Sburlan I, Rosulescu G, Bobirca A, Cerban R, Bobirca F Life (Basel). 2023; 13(2).

PMID: 36836832 PMC: 9961380. DOI: 10.3390/life13020475.


Pregnancy and medications in inflammatory bowel disease.

Cao R, Grimm M Obstet Med. 2021; 14(1):4-11.

PMID: 33995565 PMC: 8107959. DOI: 10.1177/1753495X20919214.


Immunosuppressive and Immunomodulating Therapy for Atopic Dermatitis in Pregnancy: An Appraisal of the Literature.

Heilskov S, Deleuran M, Vestergaard C Dermatol Ther (Heidelb). 2020; 10(6):1215-1228.

PMID: 33140290 PMC: 7649192. DOI: 10.1007/s13555-020-00457-w.